---
title: "Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290566258.md"
description: "On June 23, 2026, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) revealed its inclusion in an editorial released by BioMedWire (BMW). This publication was part of the Dynamic Brand Portfolio @ IBN, a specialized platform under the InvestorBrandNetwork. This network comprises over 75 brands and primarily deals with financial news and content distribution for both private and public companies, catering to the investment community."
datetime: "2026-06-23T12:32:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290566258.md)
  - [en](https://longbridge.com/en/news/290566258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290566258.md)
generator: "portal-rs"
---

# Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

On June 23, 2026, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) revealed its inclusion in an editorial released by BioMedWire (BMW). This publication was part of the Dynamic Brand Portfolio @ IBN, a specialized platform under the InvestorBrandNetwork. This network comprises over 75 brands and primarily deals with financial news and content distribution for both private and public companies, catering to the investment community.

### Related Stocks

- [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md)

## Related News & Research

- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves](https://longbridge.com/en/news/296514765.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis](https://longbridge.com/en/news/295819977.md)
- [12:26 ETThe Multiple Sclerosis Association of America (MSAA) Recognizes Ten-Year Milestone of Online Support Platform, My MSAA Community](https://longbridge.com/en/news/296518219.md)
- [EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial](https://longbridge.com/en/news/295393476.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**